365 related articles for article (PubMed ID: 29701673)
21. Cytotoxic T-Lymphocyte-Associated Antigen 4 (CTLA-4)- and Programmed Death 1 (PD-1)-Mediated Regulation of Monofunctional and Dual Functional CD4
Rajamanickam A; Munisankar S; Dolla C; Nutman TB; Babu S
Infect Immun; 2019 Dec; 87(12):. PubMed ID: 31570560
[TBL] [Abstract][Full Text] [Related]
22. The Ca2+/calmodulin-dependent kinase type IV is involved in the CD5-mediated signaling pathway in human T lymphocytes.
Gringhuis SI; de Leij LF; Wayman GA; Tokumitsu H; Vellenga E
J Biol Chem; 1997 Dec; 272(50):31809-20. PubMed ID: 9395527
[TBL] [Abstract][Full Text] [Related]
23. Human CD5 protects circulating tumor antigen-specific CTL from tumor-mediated activation-induced cell death.
Friedlein G; El Hage F; Vergnon I; Richon C; Saulnier P; Lécluse Y; Caignard A; Boumsell L; Bismuth G; Chouaib S; Mami-Chouaib F
J Immunol; 2007 Jun; 178(11):6821-7. PubMed ID: 17513730
[TBL] [Abstract][Full Text] [Related]
24. Dual blockade of PD-1 and CTLA-4 combined with tumor vaccine effectively restores T-cell rejection function in tumors.
Duraiswamy J; Kaluza KM; Freeman GJ; Coukos G
Cancer Res; 2013 Jun; 73(12):3591-603. PubMed ID: 23633484
[TBL] [Abstract][Full Text] [Related]
25. The ectodomains of the lymphocyte scavenger receptors CD5 and CD6 interact with tegumental antigens from Echinococcus granulosus sensu lato and protect mice against secondary cystic echinococcosis.
Mourglia-Ettlin G; Miles S; Velasco-De-Andrés M; Armiger-Borràs N; Cucher M; Dematteis S; Lozano F
PLoS Negl Trop Dis; 2018 Nov; 12(11):e0006891. PubMed ID: 30500820
[TBL] [Abstract][Full Text] [Related]
26. The identification and characterization of a ligand for bovine CD5.
Haas KM; Estes DM
J Immunol; 2001 Mar; 166(5):3158-66. PubMed ID: 11207268
[TBL] [Abstract][Full Text] [Related]
27. Tolerance without clonal expansion: self-antigen-expressing B cells program self-reactive T cells for future deletion.
Frommer F; Heinen TJ; Wunderlich FT; Yogev N; Buch T; Roers A; Bettelli E; Müller W; Anderton SM; Waisman A
J Immunol; 2008 Oct; 181(8):5748-59. PubMed ID: 18832734
[TBL] [Abstract][Full Text] [Related]
28. The pseudo-immunoreceptor tyrosine-based activation motif of CD5 mediates its inhibitory action on B-cell receptor signaling.
Gary-Gouy H; Bruhns P; Schmitt C; Dalloul A; Daëron M; Bismuth G
J Biol Chem; 2000 Jan; 275(1):548-56. PubMed ID: 10617650
[TBL] [Abstract][Full Text] [Related]
29. Immunological Disorders: Regulation of Ca
Srikanth S; Woo JS; Sun Z; Gwack Y
Adv Exp Med Biol; 2017; 993():397-424. PubMed ID: 28900926
[TBL] [Abstract][Full Text] [Related]
30. CD5 expression promotes IL-10 production through activation of the MAPK/Erk pathway and upregulation of TRPC1 channels in B lymphocytes.
Garaud S; Taher TE; Debant M; Burgos M; Melayah S; Berthou C; Parikh K; Pers JO; Luque-Paz D; Chiocchia G; Peppelenbosch M; Isenberg DA; Youinou P; Mignen O; Renaudineau Y; Mageed RA
Cell Mol Immunol; 2018 Feb; 15(2):158-170. PubMed ID: 27499044
[TBL] [Abstract][Full Text] [Related]
31. The calcium feedback loop and T cell activation: how cytoskeleton networks control intracellular calcium flux.
Joseph N; Reicher B; Barda-Saad M
Biochim Biophys Acta; 2014 Feb; 1838(2):557-68. PubMed ID: 23860253
[TBL] [Abstract][Full Text] [Related]
32. Lag-3, Tim-3, and TIGIT: Co-inhibitory Receptors with Specialized Functions in Immune Regulation.
Anderson AC; Joller N; Kuchroo VK
Immunity; 2016 May; 44(5):989-1004. PubMed ID: 27192565
[TBL] [Abstract][Full Text] [Related]
33. Non-CD28 costimulatory molecules present in T cell rafts induce T cell costimulation by enhancing the association of TCR with rafts.
Yashiro-Ohtani Y; Zhou XY; Toyo-Oka K; Tai XG; Park CS; Hamaoka T; Abe R; Miyake K; Fujiwara H
J Immunol; 2000 Feb; 164(3):1251-9. PubMed ID: 10640738
[TBL] [Abstract][Full Text] [Related]
34. Interaction of recombinant and natural soluble CD5 forms with an alternative cell surface ligand.
Calvo J; Places L; Padilla O; Vilà JM; Vives J; Bowen MA; Lozano F
Eur J Immunol; 1999 Jul; 29(7):2119-29. PubMed ID: 10427974
[TBL] [Abstract][Full Text] [Related]
35. The microenvironmental niche in classic Hodgkin lymphoma is enriched for CTLA-4-positive T cells that are PD-1-negative.
Patel SS; Weirather JL; Lipschitz M; Lako A; Chen PH; Griffin GK; Armand P; Shipp MA; Rodig SJ
Blood; 2019 Dec; 134(23):2059-2069. PubMed ID: 31697809
[TBL] [Abstract][Full Text] [Related]
36. KLRG1 and PD-1 expression are increased on T-cells following tuberculosis-treatment and identify cells with different proliferative capacities in BCG-vaccinated adults.
Boer MC; van Meijgaarden KE; Goletti D; Vanini V; Prins C; Ottenhoff TH; Joosten SA
Tuberculosis (Edinb); 2016 Mar; 97():163-71. PubMed ID: 26750180
[TBL] [Abstract][Full Text] [Related]
37. OX52 is the rat homologue of CD6: evidence for an effector function in the regulation of CD5 phosphorylation.
Castro MA; Nunes RJ; Oliveira MI; Tavares PA; Simões C; Parnes JR; Moreira A; Carmo AM
J Leukoc Biol; 2003 Jan; 73(1):183-90. PubMed ID: 12525577
[TBL] [Abstract][Full Text] [Related]
38. Endogenous co-expression of two T cell receptors promotes lymphopenia-induced proliferation via increased affinity for self-antigen.
Balakrishnan A; Jama B; Morris GP
J Leukoc Biol; 2018 Dec; 104(6):1097-1104. PubMed ID: 30168881
[TBL] [Abstract][Full Text] [Related]
39. Deregulated Expression of Immune Checkpoints on Circulating CD4 T Cells May Complicate Clinical Outcome and Response to Treatment with Checkpoint Inhibitors in Multiple Myeloma Patients.
Kulikowska de Nałęcz A; Ciszak L; Usnarska-Zubkiewicz L; Frydecka I; Pawlak E; Szmyrka M; Kosmaczewska A
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502204
[TBL] [Abstract][Full Text] [Related]
40. CD5 maintains tolerance in anergic B cells.
Hippen KL; Tze LE; Behrens TW
J Exp Med; 2000 Mar; 191(5):883-90. PubMed ID: 10704468
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]